Enzene Biosciences Ltd. obtains Marketing Authorization for...

Pune (Maharashtra) [India], August 20 (ANI/PRNewswire): Enzene Biosciences Ltd. "Enzene" announces a successful...

Can't prosecute good Samaritan: Delhi HC on charge against...

New Delhi [India], July 29 (ANI): The Delhi High Court on Thursday pulled up the state's Drug Controller for...

Proceedings initiated against Gautam Gambhir, AAP MLAs for...

New Delhi [India], July 17 (ANI): Delhi's Drug Controller Department told the Delhi High Court that it has...

Pfizer, Johnson and Johnson yet to apply for license of...

New Delhi [India], July 15 (ANI): The Drug Controller General of India (DCGI) has urged Pfizer, Johnson and...

Zydus Cadila seeks nod for its COVID-19 vaccine ZyCoV-D, aims...

New Delhi [India], July 1 (ANI): The pharmaceutical firm Zydus Cadila on Thursday informed that it has applied for...

DCGI grants SII permission to manufacture Sputnik V for...

New Delhi [India], June 4 (ANI): The Drug Controller General of India (DCGI) on Friday granted the approval to the...

Children can't be vaccinated currently, trials on below 18...

New Delhi [India], June 4 (ANI): Centre through an affidavit on Friday informed the Delhi High Court that on May 12,...

Gautam Gambhir Foundation guilty of illegally hoarding...

New Delhi [India], June 3 (ANI): The Drug Controller of Delhi on Thursday informed the Delhi High Court that Gautam...

Visakhapatnam: Drug control officer says DCGI gave permission...

Visakhapatnam (Andhra Pradesh) [India], June 3 (ANI): Refuting allegations that Remdesivir injections, which were...

SII seeks DCGI's permission for test license to manufacture...

New Delhi [India], June 3 (ANI): Indian vaccine manufacturing company Serum Institute of India (SII) has sought...

Delhi HC raps Drug Controller Department over probe into...

New Delhi [India], May 31 (ANI): Expressing dissatisfaction with its status report, the Delhi High Court on Monday...

COVID-19: MSN Laboratories initiates Phase III clinical trial...

New Delhi [India], May 26 (ANI): MSN Laboratories Private Limited (MSN) is initiating phase III clinical trial of...